Home » Newsletters » BioWorld Science

BioWorld Science

June 13, 2013

View Archived Issues

Phase III evaluation of a polymerase inhibitor for the treatment of drug-resistant hepatitis C

First-in-human results presented for the imaging agent [18F]FC-119S

Researchers at Biota Scientific Management present new antiviral agents

Hereditary fibrosing poikiloderma, a new condition caused by FAM111B gene mutations

Novel biomarker associated with suicide attempt in patients with MDD

Pfizer presents phase I results for a novel biosimilar of trastuzumab

Ocriplasmin receives initial recommendation for NHS reimbursement in U.K.

NeuroVive Pharmaceutical reports new collaboration and milestone payment from Sihuan

Natural derived polymer VS-501 may control serum phosphate in CKD

Derma Sciences reports data from pharmacokinetic study of DSC-127

Amgen and Cytokinetics expand license for omecamtiv mecarbil

Teprotumumab to be developed in new indication

Aphios and VivaCell to develop non-psychotropic cannabinoids

Ferrer completes phase III trial of ozenoxacin in impetigo

Roche presents new CB2 receptor agonists

Amgen reports topline results from phase III TRINOVA-1 trial

Constellation Pharmaceuticals prepares new EZH2 inhibitors for cancer

Chinese researchers patent novel HIV fusion inhibitors

Bioheart completes phase I ANGEL study

New DHODH inhibitors for malaria presented by Chinese researchers

Funding supports Madera's development of small-molecule drugs for Alzheimer's disease

Bill & Melinda Gates Foundation and European Commission partner

Nanobiotix cleared to begin study of NBTXR-3 for head and neck cancer

Exact Sciences completes PMA application for Cologuard screening test

Constella launched in Europe for the treatment of IBS-C

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...